Join
Live feed
·
INSIDERFilingvia Quantisnow
Atara Biotherapeutics Inc. logo

Director Heiden William K was granted 7,828 shares, increasing direct ownership by 55% to 22,188 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATRA· Atara Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATRA (Atara Biotherapeutics Inc.) and more on Quantisnow.